Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 64 Colorectal Neoplasms 58 Rectal Neoplasms 46 Stomach Neoplasms 44 Neoplasm Metastasis 16 Pancreatic Neoplasms 15 Colonic Neoplasms 13 Triple Negative Breast Neoplasms 11 Neoplasms 11 Esophageal Neoplasms 9 Nasopharyngeal Carcinoma 8 Locally Advanced Rectal Cancer 7 Esophageal Squamous Cell Carcinoma 7 Cholangiocarcinoma 6 Biliary Tract Neoplasms 6 Carcinoma, Hepatocellular 5 HER2 Positive Metastatic Breast Cancer 4 Colorectal Cancer Metastatic 4 Adenocarcinoma 4 Solid Tumor 3 Recurrence 3 Gallbladder Neoplasms 3 Anus Neoplasms 3 Advanced Breast Cancer 3 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumors 2 Neuroendocrine Tumors 2 Locally Advanced Colon Cancer 2 Hyperthermia 2 Head and Neck Neoplasms 2

Interventions

pertuzumab 1 penpulimab 1 dalpiciclib 1 Trastuzumab 1 Patient Reported Outcome Measures 1 Induction Chemotherapy 1 Fulvestrant 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Breast Neoplasm Female × Capecitabine × Clear all

NCT03011060 2017-01-10

NACVCAC

The First Hospital of Jilin University

Phase 3 Unknown

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡